Biotech Startup Nintx Raises US$10 Million to Accelerate Research and Development of Multifactorial Disease Treatments

Nintx secures additional funding to expedite research and development of treatments for multifactorial diseases, with a focus on addressing genetic and environmental factors, particularly those related to the human gut microbiome. Co-founder Stephani Saverio assumes the role of CEO.